MPL MEDIBANK PRIVATE LIMITED Stock Forecast Period (n+15) 29 Sep 2020


Stock Forecast


As of Tue Sep 29 2020 23:10:43 GMT+0000 (Coordinated Universal Time) shares of MPL MEDIBANK PRIVATE LIMITED -0.39 percentage change in price since the previous day's close. Around 8223397 of 2754003240 changed hand on the market. The Stock opened at 2.58 with high and low of 2.52 and 2.59 respectively. The price/earnings ratio is: 22.25 and earning per share is 0.11. The stock quoted a 52 week high and low of 2.45 and 3.47 respectively.

BOSTON (AI Forecast Terminal) Tue, Sep 29, '20 AI Forecast today took the forecast actions: In the context of stock price realization of MPL MEDIBANK PRIVATE LIMITED is a decision making process between multiple investors each of which controls a subset of design variables and seeks to minimize its cost function subject to future forecast constraints. That is, investors act like players in a game; they cooperate to achieve a set of overall goals.Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines. Machine Learning based technical analysis (n+15) for MPL MEDIBANK PRIVATE LIMITED as below:
Using machine learning modified The random walk index model RWI equivalent to a model of stock market dynamics with price expectations, we analyze the reaction of investors to speculations. Analyzing those data we were able to establish the amount by which each stock felt the speculative attacks, a dampening factor which expresses the capacity of a market of absorving a shock, and also a frequency related with volatility after the speculation. Using the correlation matrices, the speculative buffer for the shares of MPL MEDIBANK PRIVATE LIMITED as below:

MPL MEDIBANK PRIVATE LIMITED Credit Rating Overview


We rerate MPL MEDIBANK PRIVATE LIMITED because of reduce equity by the amount of unrecognized losses, after tax. This adjustment adds the surplus to reported capital when calculating ACE and TAC. We deduct from capital that amount of the surplus that we view as unrealizable. We use econometric methods for period (n+15) simulate with Tuned Collector Oscillator Logistic Regression. Reference code is: 2581. Beta DRL value REG 36 Rational Demand Factor LD 4305.6888. Other factors we consider include a company's frequency of debt issuance and market access, especially during times of company-specific stress or credit market turbulence. Credit Rating AI Process rely on primary sources of information: Sec Filings, Financial Statements, Credit Ratings, Semantic Signals. Take a look at Machine Learning section for Financial Deep Reinforcement Learning.

Oscillators are used for generating credit risk signals by using the semantic and financial signals. The value of the oscillators indicate the strength of trend. Using the correlation matrices, the risk map for MPL MEDIBANK PRIVATE LIMITED as below:
Frequently Asked QuestionsQ: What is MPL MEDIBANK PRIVATE LIMITED stock symbol?
A: MPL MEDIBANK PRIVATE LIMITED stock referred as ASX:MPL
Q: What is MPL MEDIBANK PRIVATE LIMITED stock price?
A: On share of MPL MEDIBANK PRIVATE LIMITED stock can currently be purchased for approximately 2.55
Q: Do analysts recommend investors buy shares of MPL MEDIBANK PRIVATE LIMITED ?
A: Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines. View Machine Learning based technical analysis for MPL MEDIBANK PRIVATE LIMITED at daily forecast section
Q: What is the earning per share of MPL MEDIBANK PRIVATE LIMITED ?
A: The earning per share of MPL MEDIBANK PRIVATE LIMITED is 0.11
Q: What is the market capitalization of MPL MEDIBANK PRIVATE LIMITED ?
A: The market capitalization of MPL MEDIBANK PRIVATE LIMITED is 7022708130
We work across the world

From London to San Francisco, to our home base in (Saint Helier) Jersey, we’re looking for extraordinary and creative scientists to help us drive the field forward.

Disclaimers: AC Investment Inc. currently does not act as an equities executing broker or route orders containing equities securities. All data and information is provided “as is” for personal informational purposes only, and is not intended for trading purposes or advice. Please consult your broker or financial representative to verify pricing before executing any trade.

77 Massachusetts Avenue Cambridge, MA 02139 617-253-1000 pr@ademcetinkaya.com